New Medicare-negotiated prices for 15 widely used medications take effect in 2027, impacting more than 5 million ...

CMS announced massive price reductions for 15 critical drugs, including Xtandi, Ibrance, and Janumet. See the full list and ...

Paying for prescriptions is a burden for many, but there's good news. Under the Medicare Drug Price Negotiation Program, 15 ...

May 2 (Reuters) - The U.S. health regulator on Monday approved Boehringer Ingelheim's and Eli Lilly's diabetes drug Tradjenta. The drug is to be used with diet and exercise to improve blood glucose ...

The second round of Inflation Reduction Act negotiation prices, which includes 15 brand-name drugs, will kick into effect in ...

The second round of negotiations cuts spending an aggregate 44% over 2024 list prices as the federal government extends ...

The FDA approved linagliptin to treat adults with type 2 diabetes – the form of the disease that affects between 90% and 95% of the 96 million people in the United States who have diabetes.

Linagliptin/metformin is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, ...